JP2024520690A5 - - Google Patents
Info
- Publication number
- JP2024520690A5 JP2024520690A5 JP2023574531A JP2023574531A JP2024520690A5 JP 2024520690 A5 JP2024520690 A5 JP 2024520690A5 JP 2023574531 A JP2023574531 A JP 2023574531A JP 2023574531 A JP2023574531 A JP 2023574531A JP 2024520690 A5 JP2024520690 A5 JP 2024520690A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- nitroxoline
- pharmaceutically acceptable
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2108224.3 | 2021-06-09 | ||
| GBGB2108224.3A GB202108224D0 (en) | 2021-06-09 | 2021-06-09 | Treatment |
| PCT/GB2022/051442 WO2022258972A1 (en) | 2021-06-09 | 2022-06-09 | Nitroxoline for use in the treatment of cutaneous neurofibroma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520690A JP2024520690A (ja) | 2024-05-24 |
| JP2024520690A5 true JP2024520690A5 (enExample) | 2025-06-12 |
Family
ID=76838879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574531A Pending JP2024520690A (ja) | 2021-06-09 | 2022-06-09 | 皮膚神経線維腫の治療に使用するためのニトロキソリン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240261276A1 (enExample) |
| EP (1) | EP4351576A1 (enExample) |
| JP (1) | JP2024520690A (enExample) |
| KR (1) | KR20240024175A (enExample) |
| CN (1) | CN117769419A (enExample) |
| AU (1) | AU2022290019A1 (enExample) |
| BR (1) | BR112023025789A2 (enExample) |
| CA (1) | CA3221964A1 (enExample) |
| GB (1) | GB202108224D0 (enExample) |
| IL (1) | IL309177A (enExample) |
| MX (1) | MX2023014530A (enExample) |
| WO (1) | WO2022258972A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202116743D0 (en) * | 2021-11-19 | 2022-01-05 | Healx Ltd | Treatment |
| GB202218460D0 (en) * | 2022-12-08 | 2023-01-25 | Healx Ltd | Treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970128B1 (en) * | 2013-03-15 | 2019-12-04 | Asieris Pharmaceutical Technologies Co., Ltd. | Base addition salts of nitroxoline and uses thereof |
| CA3287905A1 (en) * | 2016-10-14 | 2025-11-29 | Wake Forest University Health Sciences | Compositions, cell constructs, and methods of making and using the same |
| EP3883552B1 (en) * | 2018-11-20 | 2025-04-09 | NFlection Therapeutics, Inc. | Cyanoaryl-aniline compounds for treatment of dermal disorders |
| CN112402388A (zh) * | 2019-08-05 | 2021-02-26 | 江苏亚虹医药科技股份有限公司 | 一种用于治疗膀胱癌的口服固体制剂及其制备方法 |
-
2021
- 2021-06-09 GB GBGB2108224.3A patent/GB202108224D0/en not_active Ceased
-
2022
- 2022-06-09 KR KR1020247000745A patent/KR20240024175A/ko active Pending
- 2022-06-09 MX MX2023014530A patent/MX2023014530A/es unknown
- 2022-06-09 CA CA3221964A patent/CA3221964A1/en active Pending
- 2022-06-09 US US18/567,829 patent/US20240261276A1/en active Pending
- 2022-06-09 WO PCT/GB2022/051442 patent/WO2022258972A1/en not_active Ceased
- 2022-06-09 EP EP22732622.0A patent/EP4351576A1/en active Pending
- 2022-06-09 CN CN202280040639.5A patent/CN117769419A/zh active Pending
- 2022-06-09 IL IL309177A patent/IL309177A/en unknown
- 2022-06-09 JP JP2023574531A patent/JP2024520690A/ja active Pending
- 2022-06-09 BR BR112023025789A patent/BR112023025789A2/pt unknown
- 2022-06-09 AU AU2022290019A patent/AU2022290019A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (enExample) | ||
| JP2023541430A5 (enExample) | ||
| JP2023515472A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| RU2010147287A (ru) | Комбинированная композиция | |
| JP2024516795A5 (enExample) | ||
| JP2024534427A5 (enExample) | ||
| JP2024540439A5 (enExample) | ||
| AU2009215329B2 (en) | Combination comprising paclitaxel for treating ovarian cancer | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023522415A5 (enExample) | ||
| RU2007103306A (ru) | Композиции на основе ризедроната и способы их применения | |
| JP2016505050A5 (enExample) | ||
| JP2025148449A5 (enExample) | ||
| JP2024531799A5 (enExample) | ||
| JP2025511402A5 (enExample) | ||
| JP2025511401A5 (enExample) | ||
| JP2025509278A5 (enExample) | ||
| JP2022177119A5 (enExample) | ||
| JP2024528731A5 (enExample) | ||
| JP2023517130A5 (ja) | Ａｚｄ１６５６又はその薬学的に許容される塩を含む、コロナウイルスによって引き起こされた肺炎及び／又は心筋炎の治療用組成物 | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP2022540198A (ja) | 組合せ |